Nasal and exhaled nitric oxide in chronic rhinosinusitis with polyps

被引:42
|
作者
Jeong, Jin Hyeok [1 ]
Yoo, Han Seok [1 ]
Lee, Seung Hwan [1 ]
Kim, Kyung Rae [1 ]
Yoon, Ho Joo [2 ]
Kim, Sang Heon [2 ]
机构
[1] Hanyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul 133792, South Korea
[2] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133792, South Korea
关键词
INCREASED EXPRESSION; SYNTHASE;
D O I
10.2500/ajra.2014.28.3984
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: The ciliary epithelial cells in the paranasal sinuses produce nasal nitric oxide (NO) continuously and plays a variety of roles in the paranasal sinuses. The purpose of this study was to assess whether we can use the levels of nasal NO (nNO) and exhaled NO (eNO) as a tool for evaluation in chronic rhinosinusitis (CRS) with nasal polyp patients. Methods: We used chemiluminescent NO analyzer to measure nNO and eNO among normal controls (32) and CRS with polyp (30) and CRS with polyp and allergic rhinitis patients (27) and compared it with various clinical symptoms, laboratory data, and computed tomography (CT) scores. Results: Levels of nNO were significantly lower in patients with CRS with polyps (88.5 +/- 54.7 ppb) compared with controls (241.0 +/- 89.5 ppb). Levels of nNO in CRS with polyps and allergic rhinitis (167.0 +/- 47.6 ppb) were significantly higher than CRS with polyps and lower than controls. A significant inverse relationship was observed between nNO and sinus CT scores, severity of nasal obstruction, and purulent rhinorrhea in CRS with polyps. Low values of nNO separated well patients with CRS with polyps, and the cutoff value of < 163 ppb was associated with the best combination of specificity (93%) and sensitivity (81%). A significant positive relationship was observed between eNO and CT scores. Conclusion: The nNO could be used for another screening of CRS with polyps for the more severe phenotypes, which may eventually have to be treated with surgery.
引用
收藏
页码:E11 / E16
页数:6
相关论文
共 50 条
  • [41] A new treatment for chronic rhinosinusitis with nasal polyps
    Stevens, Whitney W.
    LANCET, 2019, 394 (10209): : 1595 - 1597
  • [42] Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps
    Sheridan M. Hoy
    Drugs, 2020, 80 : 711 - 717
  • [43] The microbiology of chronic rhinosinusitis with and without nasal polyps
    Liu, Qinghua
    Lu, Xinxin
    Bo, Mingyu
    Qing, Hui
    Wang, Xiangdong
    Zhang, Luo
    ACTA OTO-LARYNGOLOGICA, 2014, 134 (12) : 1251 - 1258
  • [44] Biological therapy in chronic rhinosinusitis with nasal polyps
    Jin, Zeyi
    Yan, Bing
    Zhang, Luo
    Wang, Chengshuo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2025,
  • [45] Chronic rhinosinusitis with nasal polyps: changing expectations
    Piltcher, Otavio B.
    BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2024, 90 (02)
  • [46] Treatable traits in chronic rhinosinusitis with nasal polyps
    Heffler, Enrico
    Malvezzi, Luca
    Pirola, Francesca
    Zieba, Natalia
    Paoletti, Giovanni
    Mercante, Giuseppe
    Spriano, Giuseppe
    Canonica, Giorgio Walter
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 19 (04) : 373 - 378
  • [47] The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps
    Bachert, Claus
    Desrosiers, Martin Y.
    Hellings, Peter W.
    Laidlaw, Tanya M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (03): : 1099 - 1106
  • [48] The role of macrolides in chronic rhinosinusitis and nasal polyps
    Suzaki, Isao
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 25 (01) : 19 - 26
  • [49] Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps
    Bachert, Claus
    Gevaert, Philippe
    Hellings, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (06): : 1512 - 1516
  • [50] Budesonide therapy for chronic rhinosinusitis with nasal polyps
    Kessing, Richard
    LARYNGO-RHINO-OTOLOGIE, 2024, 103 (11) : 769 - 770